Haley Young
Physician Assistant · North Aurora, ILNPI 1073157582
Payments from drug & device makers
Across 267 payments — averaging $19.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$611
- AstraZeneca$557
- GSK$547
- CSL Behring$510
- Sanofi$364
- Regeneron Healthcare Solutions, Inc.$292
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,14499%
- Education$741%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $611 |
| AstraZeneca | 26 | $557 |
| GSK | 40 | $547 |
| CSL Behring | 23 | $510 |
| Sanofi | 18 | $364 |
| Regeneron Healthcare Solutions, Inc. | 11 | $292 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $268 |
| Amgen | 15 | $268 |
| Optinose US, Inc. | 17 | $227 |
| Hospira, Inc. | 9 | $197 |
| Biocryst US Sales Co., LLC | 7 | $153 |
| Covis Pharma GmbH | 6 | $137 |
| Kaleo, Inc. | 6 | $126 |
| QOL Medical, LLC | 5 | $113 |
| Grifols USA, LLC | 5 | $98 |
| Blueprint Medicines Corporation | 3 | $80 |
| Boehringer Ingelheim | 4 | $69 |
| Pharming Healthcare, Inc. | 3 | $69 |
| Cleerly, Inc. | 2 | $59 |
| Octapharma USA, Inc. | 2 | $54 |
| Aimmune Therapeutics, Inc. | 3 | $54 |
| Sanofi-aventis U.S. LLC | 1 | $49 |
| Nestle Healthcare Nutrition Inc. | 2 | $43 |
| Pfizer | 2 | $40 |
| Alk-abello, Inc | 2 | $37 |
| Phadia US Inc. | 2 | $32 |
| Bio Products Laboratory USA, Inc. | 2 | $27 |
| Genentech USA, Inc. | 1 | $26 |
| Tersera Therapeutics LLC | 1 | $19 |
| Novartis | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Incyte Corporation | 1 | $16 |
| IBSA Pharma Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
| Biofrontera Inc. | 1 | $11 |
How this compares
$5,218 in reported general payments places this provider in the 90th percentile of 3,912 physician assistant providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 16 | $6,370 |
| Azelastine Hcl | 16 | $580 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $303 |
| Levocetirizine Dihydrochloride | 14 | $289 |
| Ipratropium Bromide | 14 | $256 |
| Montelukast Sodium | 23 | $239 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta | $547 | $6,37016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in North Aurora
- Andrew MastroChicago$419K
- Christopher AricoSkokie$407K
- Karlijn BurridgeWestmont$144K
- Ian MackeySkokie$135K
- Stephanie TraceyItasca$122K
- Olabimpe PhilipsAddison$103K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
- Darrel CutlerHerrin$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.